Ensysce Biosciences, Inc. Share Price

Ensysce Biosciences, Inc. Share Price

NASDAQ: ENSC | Micro Cap
$0.45
+$0.01 (3.42%) Last updated on 28 Oct, 2026 | 01:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Ensysce Biosciences, Inc. Stock Performance

Open
$0.44
Prev. Close
$0.44
Circuit Range
N/A
Day Range
$0.44 - $0.45
Year Range
$0.23 - $2.18
Volume
1,022
Average Traded
$0.45

Ensysce Biosciences, Inc. Share Price Today

As of 29 October 2026, Ensysce Biosciences, Inc.'s share price is $0.45. The stock opened at $0.44, compared to its previous close of $0.44. During today's trading session, Ensysce Biosciences, Inc.'s share price traded between $0.44 and $0.45, with an average price of $0.45. Over the past 52 weeks, the stock has recorded a high of $2.18 and a low of $0.23. In terms of performance, Ensysce Biosciences, Inc.'s share price has risen by 18.73% over the last six months and is down 79.17% on a year-on-year basis.

Ensysce Biosciences, Inc. Share Price Chart

Line chart of the Ensysce Biosciences, Inc. price trend over the selected period. The price rose overall, ranging from 0.45 to 0.45, ending at 0.45.
$0.44$0.45
L
Show Current Price
H

Ensysce Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.15M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.65
Revenue (TTM)
$5.07B
Return On Equity (TTM)
1614.94%
Profit Margin
-200.79%
Debt to Equity
-0.25
Quarterly Earnings Growth YoY
31.10%

Ensysce Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.49$1.88$0.96$1.16
Net Profit-$3.73-$2.77-$3.56-$2.57
Net Profit Margin-761.22%-147.34%-370.83%-221.55%
Income ChangeN/A25.74%-28.52%27.81%

Ensysce Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.52$2.23$5.21$5.07
Net Profit-$25.09-$10.63-$7.99-$10.18
Net Profit Margin-995.63%-476.68%-153.36%-200.79%
Income ChangeN/A57.63%24.84%-27.41%

About Ensysce Biosciences, Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Ensysce Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.42
$0.45
+7.40%
Sep 2026
$0.39
$0.42
+5.28%
Aug 2026
$0.26
$0.40
+54.26%
Jul 2026
$0.30
$0.26
-10.10%
Jun 2026
$0.27
$0.29
+1.77%
May 2026
$0.35
$0.28
-25.59%
Apr 2026
$0.57
$0.38
-31.09%
Mar 2026
$0.54
$0.55
-12.00%
Feb 2026
$0.69
$0.63
-13.91%
Jan 2026
$0.90
$0.73
-21.34%
Dec 2025
$1.79
$0.92
-47.85%
Nov 2025
$2.14
$1.77
-18.06%

ENSC Share Price FAQs